Anhedonia and increased stress sensitivity: Two promising endophenotypes for major depression

Current Psychiatry Reviews

Volumn 5, Issue 3, 2009, Pages 143-152

  Vrieze, Elske ^a   Claes, Stephan J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Anhedonia; Depression; HPA axis; Phenotype; Reward sensitivity; Stress

Indexed keywords

ARGIPRESSIN; CATECHOL METHYLTRANSFERASE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR 4; DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANHEDONIA; ANXIETY; CINGULATE GYRUS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EARLY LIFE STRESS; ELECTROENCEPHALOGRAM; FAMILIAL DISEASE; GENE SEGREGATION; HEREDITY; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRESS; VENTRAL TEGMENTUM;

EID: 70449591285     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340009788971083     Document Type: Review

References (184)

1. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-645
2. Tsuang MT, Faraone SV, Lyons MJ. Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatry Cli Neurosci 1993; 243: 131-142
3. Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes in major depression. Neuropsychopharmacology 2004; 29: 1765-1781
4. American Psychiatric Association In: Diagnosic and statistical manual of mental disorders (4th ed., text revision). Washington DC, American Psychiatric Press. 2000.
5. Berrios GEOlivares JM. The anhedonias: a conceptual history. Hist Psychiatry 1995; 6: 453-470
6. Peterson, CA, and Knudson, RM. Anhedonia: a construct validation approach. J Pers Assess 1983; 47: 539-551
7. Meehl PE. Hedonic capacity: some conjectures. Bull Menninger Clin 1975; 39: 295-307.
8. Meehl PE. Primary and secondary hypohedonia. J Abnorm Psychol 2001; 110(1): 188-193
9. Klein DF. Endogenomophic depression: A conceptual and terminological revision. Arch Gen Psychiatry 1974; 31: 447-454
10. Snaith P. Anhedonia: a neglected symptom of psychopathology. Psychol Med 1993; 23(4):957-966
11. Snaith P, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry 1995; 167(1): 99-103. (Pubitemid 26124582)
12. Franken IHA, Rassin E, Muris P. The assessment of anhedonia in clinical and nonclinical populations: Futher validation of the Snaith-Hamilton pleasure scale (SHAPS). J Affect Disord 2007; 99(1-3): 83-89 (Pubitemid 46275022)
13. Fawcett J, Clark DC. Scheftner WA. Gibbons RD. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry 1983; 40: 79-84.
14. Gard EG, Gard MG, Kring AM, John OP. Anticipatory and consumetory components of the experience of pleasure: a scale development study. J Res 2006; 40: 1086-1102
15. Leventhal AM, Chasson GS, Tapia E, Miller EK, Pettit JW. Measuring hedonic capacity in depression: A psychometric analysis of three anhedonia scales. J Clin Psychol 2006; 62(12): 1545-1558 (Pubitemid 44862645)
16. Berlin I, Givry-Steiner L, Lecrubier Y, Puech AJ. Measures of anhedonia and emotional responses to sucrose in depressive and schizophrenic patients in comparison with health subjects. Eur Psychiatry 1998; 13: 303-309 (Pubitemid 29169880)
17. Loas G, Salinas E, Guelfi JD, Samuel-Lajeunesse B. Physical anhedonia in major depressive disorder. J Affect Disord 1992; 25(2): 139-146
18. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100(3): 316-336
19. Davidson RJ. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003; 40(5): 655-665
20. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54(6): 1063-1070
21. Sloan DM, Strauss ME, Wisner KL. Diminished response to pleasant stimuli by depressed women. J Abnorm Psychol 2001; 110(3): 488-493
22. Dunn BD, Dalgleish T, Lawrence AD, Cusack R, Ogilvie AD. Categorical and dimensional reports of experienced affect to emotion-inducing pictures in depression. J Abnorm Psychol 2004; 113: 654-660 (Pubitemid 39431119)
23. Henriques JB, and Davidson RJ. Decreased responsiveness to reward in depression. Cogn Emotion 2000; 14(5): 711-724
24. Rottenberg J, Gross JJ, Gotlib IH. Emotion context insensitivity in major depressive disorder. J Abnorm Psychol 2005; 114(4): 627-639 (Pubitemid 41746999)
25. Kaviani H, Gray JA, Checkley SA, Raven PW, Wilson GD, Kumari V. Affective modulation of the startle response in depression: influence of the severity of depression, anhedonia, and anxiety. J Affect Disord 2004; 83(1): 21-31. (Pubitemid 39488386)
26. Bylsma LM, Morris BH, Rottenberg J. A meta-analysis of emotional reactivity in major depressive disorder. Cl Psychol Rev 2008; 28: 676-691.
27. Watson D, Weber K, Assenheimer JS, Clark LA, Strauss ME, McCormick RA. Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol 1995; 104(3): 542-545
28. Joiner TE, Brown JS, Metalsky GI. A test of the tripartite model's prediction of anhedonia's specific to depression: patients with major depression versus patients with schizophrenia. Psychiatry Res 2003; 119(3): 243-250
29. Fawcett J, Clark DC, Scheftner WA, Hedeker D. Differences between anhedonic and normally hedonic depressive states. Am J Psychiatry 1983; 140(8): 1027-1030
30. Kasch KL, Rottenberg J, Arnow BA, Gotlib IH. Behavioral activation and inhibition systems and the severity and course of depression. J Abnorm Psychol 2002; 111(4): 589-597 (Pubitemid 35247004)
31. Lemke MR, Puhl P, Koethe N, Winkler T. Psychomotor retardation and anhedonia in depression. Acta Psychiatr Scand 1999; 99(4): 252-256
32. Buckner JD, Joiner TE Jr, Pettit JW, Lewinsohn PM, Schmidt NB. Implications of the DSM's emphasis on sadness and anhedonia in major depressive disorder. Psychiatry Res 2008; 159(1-2): 25-30.
33. Pizzagalli DA, Iosifescu D, Hallett LA, Ratner KG, Fava M. Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task. J Psychiatr Res 2008; 43(1): 76-87.
34. Pizzagalli DA, Jahn AL, O'Shea JP. Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry 2005; 57: 319-327
35. Berridge KC, Robinson TE. Parsing reward. Trends Neurosci 2003; 26(9): 507-513
36. Schultz W, Tremblay L, Hollerman JR. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 1998; 37(4-5): 421-429 (Pubitemid 28306931)
37. Dunn RT, Kimbrell TA, Ketter TA, et al. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry 2002; 51(5): 387-399
38. Milak MS, Parsey RV, Keilp J, Oquendo MA, Malone KM, Mann JJ. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 2005; 62(4): 397-408. (Pubitemid 40471689)
39. Kumar P, Waiter G, Ahearn T, Milders M, Reid I, Steele JD. Abnormal temporal difference reward-learning signals in major depression. Brain 2008; 131( 8): 2084-2093
40. Mitterschiffthaler MT, Kumari V, Malhi GS, et al. Neural response to pleasant stimuli in anhedonia an fMRI study. Neuroreport 2003; 14(1): 77-182. (Pubitemid 36308405)
41. Kumari V, Mitterschiffthaler MT, Teasdale JD, et al. Neural abnormalities during cognitive generation of affect in treatment-resistant depression. Biol Psychiatry 2003; 54(8): 777-791 (Pubitemid 37205129)
42. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry 2002; 59(7): 597-604. (Pubitemid 34747239)
43. Keedwell PA, Andrew C, Williams SCR, Brammer MJ, Philips ML. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 2005; 58: 843-853 (Pubitemid 41790711)
44. Epstein J, Pan H, Kocsis JH, et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 2006; 163(10): 1784-1790 (Pubitemid 44522488)
45. Knutson B. and Wimmer GE. Splitting the difference: How does the brain code reward episodes? Ann NY Acad Sci 2007; 1104: 54-69.
46. Dillon DG, Holmes AJ, Jahn AL, Bogdan R, Wald LL, Pizzagalli DA. Dissociation of neural regios associated with anticipatory versus Consummatory phases of incentive processing. Psychophysiology 2008; 45: 36-49. (Pubitemid 350233264)
47. Wrase J, Kahnt T, Schlagenhauf F, Beck A, Cohen MX, Knutson B, Heinz A. Different neuronal systems adjust motor behaviour in response to reward and punishment. Neuroimage 2007; 36: 1253-1262 (Pubitemid 47007714)
48. Ikemoto S and Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: A unifying interpretation with special reference to reward-seeking. Brain Res Rev 1999; 31: 6-41. (Pubitemid 30009611)
49. Rogers RD, Ramnani N, Mackay C, et al. Distinct proportions of anterior cingulated cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition. Biol Psych 2004; 55: 594-602. (Pubitemid 38315033)
50. Kennerly SW, Walton ME, Behrens TEJ, Buckley MJ, Rushwoth MFS. Optimal decision making in the anterior cingulated cortex. Nat Neurosci 2006; 9: 940-947 (Pubitemid 43980509)
51. Bechara A, Damasio H, Damasio AR. Emotions, decision making and the orbitofrontal cortex. Cerebral Cortex 2000; 10: 295-307. (Pubitemid 30159296)
52. Davidson RJ, Shackman AJ, Maxwell JS. Asymmetries in face and brain related to emotion. Trends Cogn Sci 2004; 8(9):389-391
53. Davidson RJ. Well-being and affective style: neural substrates and biobehavioural correlates. Philos Trans R Soc Lond B Biol Sci 2004; 359(1449): 1395-1411
54. Shankman SA, Klein DN, Tenke CE, Bruder GE. Reward sensitivity in depression: a biobehavioral study. J Abnorm Psychol 2007; 116(1): 95-104.
55. Pizzagalli DA, Sherwood RJ, Henriques JB, Davidson RJ. Frontal brain asymmetry and reward responsiveness a source-localization study. Psychol Sci 2005; 16(10): 805-813
56. Thibodeau R, Jorgensen RS, Kim S. Depression, anxiety, and resting frontal EEG asymmetry: a meta-analytic review. J Abnorm Psychol 2006; 15(4): 715-729 (Pubitemid 44747800)
57. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiol 2005; 52(2):90-110. (Pubitemid 41160326)
58. Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U. Anhedonia and motivational deficits in rats: Impact of chronic social stress. Beh Brain Res 2005; 162: 127-134 (Pubitemid 40731540)
59. Stamford JA, Muscat R, O'Connor JJ, et al. Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine. Psychopharmacology (Berl) 1991; 105(2): 275-282
60. Lucas LR, Celen Z, Tamashiro KL, et al. Repeated exposure to social stress has long-term effects on indirect markers of dopaminergic activity in brain regions associated with motivated behaviour. Neuroscience 2004; 124(2): 449-457 (Pubitemid 38229664)
61. Bressan RA, Crippa JA. The role of dopamine in reward and pleasure behaviour - review of data from preclinical research. Acta Psychiatr Scand 2005; 111 (427): 14-21.
62. Gershon AA, Vishne T, Grunhaus L. Dopamine D2-like receptors ands the antidepressant response. Biol Psychiatry 2007; 61: 145-153 (Pubitemid 46072787)
63. Papakostas GI. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 2006; 16(6): 391-402.
64. Orsetti M, Canonico PL, Dellarole A, Colella L, Di Brisco F, Ghi P. Quetiapine prevents anhedonia induced by acute or chronic stress. Neuropsychopharmacology 2007; 32(8): 1783-1790 (Pubitemid 47076374)
65. Tremblay LK, Naranjo CA, Graham SJ, et al. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 2005; 62: 1228-1236
66. Parsey RV, Oquendo MA, Zea-Ponce Y, et al. Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biol Psychiatry 2001; 50(5): 313-322
67. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007; 64: 327-337
68. Heath AC, Cloninger CR, Martin NG. Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck. J Pers Soc Psychol 1994; 66(4): 762-775
69. Keller MC, Coventry WL, Heath AC, Martin NG Widespread evidence for non-additive genetic variation in Cloninger's and Eysenck's personality dimensions using a twin plus sibling design. Behav Genet 2005; 35(6): 707-721
70. Ono Y, Ando J, Onoda N, Yoshimura K, Momose T, Hirano M, Kanba S. Dimensions of temperament as vulnerability factors in depression. Mol Psychiatry 2002; 7(9): 948-953 (Pubitemid 35333049)
71. Farmer A, Mahmood A, Redman K, Harris T, Sadler S, McGuffin P. A sib-pair study of the temperament and character inventory scales in major depression. Arch Gen Psychiatry 2003; 60(5): 490-496 (Pubitemid 36539058)
72. Berenbaum H, Oltmanns TF, Gottesman II. Hedonic capacity in schizophrenics and their twins. Psychol Med 1990; 20(2): 367-374 (Pubitemid 20169847)
73. Hay DA, Martin NG, Foley D, Treloar SA, Kirk KM, Heath AC. Phenotypic and genetic analyses of a short measure of psychosis-proneness in a large-scale Australian twin study. Twin Res 2001; 4(1): 30-40. (Pubitemid 32910646)
74. Blanchard JJ, Horan WP, Brown SA. Diagnostic differences in social anhedonia: a longitudinal study of schizophrenia and major depressive disorder. J Abnorm Psychol 2001; 110(3): 363-371
75. Harvey PO, Pruessner J, Czechowska Y, Lepage M. Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects Mol Psychiatry 2007; 12(8): 767-775
76. Luby JL, Mrakotsky C, Heffelfinger A, Brown K, Spitznagel E. Characteristics of depressed preschoolers with and without anhedonia: evidence for a melancholic depressive subtype in young children. Am J Psychiatry 2004; 161(11): 1998-2004. (Pubitemid 39441399)
77. Hayden EP, Klein DN, Durbin CE, Olino TM. Positive emotionality at age 3 predicts cognitive style in 7 year old children. Develop Psychopathol 2006; 18: 409-423
78. Schrader GD. Does anhedonia correlate with depression severity in chronic depression? Comprehen Psychiatry 1997; 38: 260-263
79. Durbin BW, Klein DN, Nayden EP, Buckley ME, Moerk KC. Temperamental emotionality in preschoolers and parental mood disorders. J Abnorm Psychol 2005; 114: 28-37.
80. Oquendo MA, Barrera A, Ellis SP, et al. Instability of symptoms in recurrent major depression: a prospective study. Am J Psychiatry 2004; 161: 255-261 (Pubitemid 38419276)
81. Etian B, Roy I, Henry C, et al. No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorders. Bipolar disorders 2007; 9: 706-712. (Pubitemid 350042405)
82. Funke B, Malhotra AK, Finn CT, et al. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 2005; 1: 19. (Pubitemid 44848776)
83. Massat I, Souery D, Del-Favero J, et al. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry 2005; 10(6): 598-605. (Pubitemid 40897044)
84. López León S, Croes EA, Sayed-Tabatabaei FA, Claes S, Van Broeckhoven C, van Duijn CM. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a metaanalysis. Biol Psychiatry 2005; 157(9): 999-1003. (Pubitemid 40603082)
85. Vanness SH, Owens MJ, Kilts CD. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 2005; 6: 55.
86. Mattay VS, Goldberg TE, Fera F, et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 2003; 100(10): 6186-6191 (Pubitemid 36576952)
87. Baune BT, Hohoff C, Berger K, et al. Association of the COMT val158met Variant with Antidepressant Treatment Response in Major Depression. Neuropsychopharmacology 2008; 33(4): 924-932 (Pubitemid 351252697)
88. Wichers M, Aguilera M, Kenis G, et al. The Catechol-O-Methyl Transferase Val(158)Met polymorphism and experience of reward in the flow of daily life. Neuropsychopharmacology 2008; 33(13): 3030-3036
89. Yacubian J, Sommer T, Schroeder K, et al. Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci USA 2007; 104(19): 8125-8130 (Pubitemid 47185886)
90. Forbes EE, Brown SM, Kimak M, Ferrell RE, Manuck SB, Hariri AR. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 2009; 14(1): 60-70.
91. Cooper CL, Dewe P. In: Stress: A brief history. Blackwell publishing, 2004.
92. McMahon SD, Grant KE, Compas BE, Thurm AE, Ey S. Stress and psychopathology in children and adolescents: is there evidence of specificity? J Child Psychol Psychiatry 2003; 44(1):107-133
93. Kessler RC. The effect of stressful life events on depression. Ann Ev Psychol 1997; 48: 191-214. (Pubitemid 127485175)
94. Hammen C. Stress and depression. Ann Rev Clin Psychol 2005; 1: 293-319.
95. Cohen S, Kamarck T, Mermelstein R. A global measure of preceived stress. J Health Soc Behav 1983; 24: 385-396
96. Brown GW, Harris TO. In: Social Origins of Depression: A Study of Depressive Disorder in Women. New York, Free Press, 1978.
97. Williamson DE, Birmaher B, Dahl RE, Ryan ND. Stressful life events in anxious and depressed children. J Child Adolesc Psychopharmacol 2005; 15(4): 571-580 (Pubitemid 41434362)
98. Kendler KS, Thornton LM, Prescott CA. Gender differences in the rate of exposure to stressful life events and sensitivity to their depressogenic effect. Am J Psychiatry 2001; 158: 587-593
99. Heim C, Plotsky PM, Nemeroff CB. Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacologyjavascript:AL-get-(this, 'jour', 'Neuropsychopharmacology.'); 2004; 29(4): 641-648 (Pubitemid 38402471)
100. Tarullo AR, Gunnar MR. Childhood maltreatment and the development of the HPA-axis. Horm Behav 2006; 50: 632-639.
101. Gunthert KC, Cohen LH, Armeli S. The role of neuroticism in daily stress and coping. J Pers Soc Psychol 1999; 77(5): 1087-1100
102. Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression Am J Psychiatry 2004; 161(4): 631-636
103. Ilgen MA, Hutchison KE. A history of major depressive disorder and the response to stress. J Affect Disord 2005; 86: 143-150 (Pubitemid 40780026)
104. Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the kindling hypothesis. Am J Psychiatry 2000; 157: 1243-1251
105. Charney DS. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry 2004; 161(2): 195-216.
106. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocriene factors and stress. J Psychosom Res 2002; 53: 865-871 (Pubitemid 35282615)
107. Chrousos GP, Gold PW. The concept of stress and stress system disorder: overview of physical and hehavioral homeostasis. JAMA 1992; 267(9): 1244-1252.
108. Kudielka BM, Kirschbaum C. Sex differences in HPA axis response to stress: a review. Biol Psychol 2005; 69: 113-132. (Pubitemid 40299386)
109. Claes S. Corticotropin-relaesing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med 2004; 36: 50-61. (Pubitemid 38230699)
110. Makino S, Hashimoto K, Gold PW. Multiple feedback mechanisms activating corticotrophin-releasing hormone system in the brain during stress. Pharm Bioch Behav 2002; 73: 147-158. (Pubitemid 34667027)
111. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry 2004; 55(1):1-9.
112. Joëls M, Karst H, Alfarez D, et al. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004; 7(4): 221-231 (Pubitemid 40591422)
113. Raone A, Cassanelli A, Scheggi S, Rauggi R, Danielli B, De Montis MG. Hypothalamus-pituitary-adrenal modifications consequent to chronic stress exposure in an experimental model of depression in rats. Neuroscience 2007; 146(4): 1734-1742 (Pubitemid 46783225)
114. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 2001; 57(1-3): 141-152 (Pubitemid 32651897)
115. Gold PW, Chrousos GP. The endocrinology of melancholic and atypical depression: relation to neurocircuit and somatic consequences. Proc Assoc Am Phy 1999; 111: 22-34.
116. Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 2007; 10 (1): 13-25. (Pubitemid 46440564)
117. Nemeroff CB, Widerlov E, Bissette G, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984; 226 (4680): 1342-1344 (Pubitemid 15215592)
118. Risch SC, Lewine RJ, Kalin NH, et al. Limbic-hypothalamic-pituitary- adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia. Neuropsychopharmacology 1992; 6(2): 95-100.
119. Nemeroff CB, Krishnan KR, Reed D, Leder R, Beam C, Dunnick NR. Adrenal gland enlargement in major depression: a compted tomographic study. Arch Gen Psychiatry 1992; 49: 384-387
120. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 2003; 28(7): 1328-1335 (Pubitemid 41070903)
121. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60: 436-444
122. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psych 1976; 33: 1039-1044
123. Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH. The dex/CRH test - is it better than the DST? Psychoneuroendocrinology 2006; 31(7): 889-894
124. Young EA, Kotun J, Haskett RF, et al. Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch Gen Psychiatry 1993; 50(5): 395-403. (Pubitemid 23143129)
125. Holsbroer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23: 477-501.
126. Zobel AW, Yassouridis A, Frieboes RM, Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry 1999; 156(6): 949-951 (Pubitemid 29260354)
127. Van Den Eede F, Claes SJ. Assessment of the validity of the dexamethasone/corticotropin-releasing hormone test. Comment on: Watson, S., Gallagher P, Smith MS, Ferrier IN, Young AH. The dex/CRH test - is it better than the DST? Psychoneuroendocrinology. 2006; 31: 889-894. Psychoneuroendocrinology 2007; 32(1): 91. Author reply 92-94
128. Gold PW, Drevets WC, Charney DS. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 2002; 52: 381-385.
129. Dickerson SS, and Kemeny ME. Acute Stressors and Cortisol Responses: A theoretical integration and synthesis of laboratory research. Psychol Bull 2004; 130(3): 355-391
130. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology 2000; 23(4): 411-418
131. Young EA, Abelson JL, Cameron OG. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry 2004; 56(2): 113-120
132. Heim C, Newport DJ, Heit S, et al. Pituitary-adrenal and autonomic response to stress in women after sexual and physical abuse in childhood. JAMA 2000; 284(5): 592-597 (Pubitemid 30622145)
133. Oswald LM, Zandi P, Nestadt G, Potash JB, Kalaydjiam AE, Wand GS. Relationship between cortisol response to stress and personality. Neuropsychopharmacology 2006; 31: 1583-1591 (Pubitemid 43910453)
134. Tyrka AR, Wier LM, Anderson GM, Wilkinson CW, Price LH, Carpenter LL. Temperament and response to the Trier Social Stress Test. Acta Psychiatr Scand 2007; 115(5): 395-402.
135. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HI, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157: 115-118. (Pubitemid 30027430)
136. Vythilingam M, Heim C, Newport J, et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry 2002; 159: 2072-2080 (Pubitemid 35423868)
137. Hastings RS, Parsey RV, Oquendo MA, Arango V, Mann JJ. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004; 29(5): 952-959
138. Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 2002; 71(3): 431-447 (Pubitemid 34126368)
139. Drevets WC, Ongür D, Price JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry 1998; 3(3): 220-6, 190-191 (Pubitemid 28266331)
140. Mason BL, Pariante CM. The effects of antidepressants on the hypothalamic-pituitary-adrenal axis. Drug News Perspect 2006; 19(10): 603-608
141. Schüle C. Neuroendocrinological mechanisms of action of antidepressant drugs. J Neuroendocrinol 2006; 19: 213-226.
142. Burke HM, Davis MC, Otte C, Mohr DC. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 2005; 30(9): 846-856 (Pubitemid 40977907)
143. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157(10): 1552-1562 (Pubitemid 30761024)
144. Holsboer F, Lauer CJ, Schreiber W, Krieg JC. Altered hypothalamic- pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 1995; 62: 340-347.
145. Kendler KS, Prescott C. A population-based twin study of life time major depression in men and women. Arch Gen Psychiatry 1999; 56: 39-44. (Pubitemid 29055048)
146. Tennant C. Life events, stress and depression: a review of recent findings. Aust N Z J Psychiatry 2002; 36(2): 173-182 (Pubitemid 34746443)
147. Kendler KS, Gatz M, Gardner CO, Pedersen NL. Personality and major depression. A Swedish longitudinal population-based twin study. Arch Gen Psychiatry 2006; 63: 1113-1120
148. Fanous AH, Neale MC, Aggen SH, Kendler KS. A longitudinal study of personality and major depression in a population-based sample of male twins. Psychol Med 2007; 37(8): 1163-1172
149. Levinson DF. The genetics of depression: A review. Biol Psychiatry 2006; 60: 84-92.
150. Jabbi M, Korf J, Ormel J, Kema IP, den Boer JA. Investigating the molecular basis of major depressive disorder etiology: a functional convergent genetic approach. Ann NY Acad Sci 2008; 1148: 42-56.
151. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7(8): 847-854
152. Wichers M, Schrijvers D, Geschwind N, et al. Mechanisms of gene-environment interactions in depression: evidence that genes potentiate multiple sources of adversity. Psychol Med 2008: 1-10.
153. Ouellet-Morin I, Boivin M, Dionne G, et al. Variations in heritability of cortisol reactivity to stress as a function of early familial adversity among 19-month-old twins. Arch Gen Psychiatry 2008; 65(2): 211-218 (Pubitemid 351214320)
154. Maccari S, morley-fletcher S. Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alteraltions. Psychoneuroendocrinology 2007; 32: S10-S15.
155. Weinstock M. The long-term behavioural consequences of prenatal stress. Neurosci Biobehav Rev 2008; 32(6): 1073-1086
156. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389 (Pubitemid 36877077)
157. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62(5): 529-535 (Pubitemid 40628882)
158. Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 2006; 60(7): 671-676
159. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 2005; 62(5): 529-535 (Pubitemid 40628882)
160. Barr CS, Newman TK, Shannon C, et al. Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques. Biol Psychiatry 2004; 55(7): 733-738 (Pubitemid 38376185)
161. Gotlib IH, Joormann J, Minor KL, Hallmayer J. HPA axis reactivity: A mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol Psychiatry 2007; 63(9): 847-851
162. Jabbi M, Korf J, Kema IP, et al. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol Psychiatry 2007; 12(5): 483-490 (Pubitemid 46652463)
163. Muller MB, Uhr M, Holsboer F, Keck ME. Hypothalamic-pituitary- adrenocortical system and mood disorders: highlights from mutant mice. Neuroendocrinology 2004; 79: 1-12. (Pubitemid 38186449)
164. Pariante CM. Glucocorticoid receptor function in vitro in patients with major depression. Stress 2004; 7(4): 209-219
165. van West D, Van Den Eede F, Del-Favero J, et al. Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression. Neuropsychopharmacology 2006; 31(3): 620-627 (Pubitemid 43276977)
166. van Rossum EF, Binder EB, Majer M, et al. Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry 2006; 59(8): 681-688
167. Claes S, Villafuerte S, Forsgren T, et al. The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden. Biol Psychiatry 2003; 54: 867-872 (Pubitemid 37311347)
168. Liu Z, Zhu F, Wang G, et al. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression. Neurosci Lett 2006; 404: 358-362 (Pubitemid 44108440)
169. Bradley RG, Binder EB, Epstein MP, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene Arch Gen Psychiatry 2008; 65: 190-200.
170. van West D, Del-Favero J, Aulchenko Y, et al. A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent depression. Mol Psychiatry 2004; 9: 287-292 (Pubitemid 38496720)
171. Dempster EL, Burcescu I, Wigg K, et al. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders. Arch Gen Psychiatry 2007; 64(10): 1189-1195 (Pubitemid 47529343)
172. Oei TI, Verhoeven WM, Westenberg HG, Zwart FM, van Ree JM. Anhedonia, suicide ideation and dexamethasone nonsuppression in depressed patients. J Psychiatr Res 1990; 24(1): 25-35.
173. Bogdan R, Pizzagalli DA.The heritability of hedonic capacity and perceived stress: a twin study evaluation of candidate depressive phenotypes. Psychol Med 2009; 39(2): 211-218
174. Bogdan R, Pizzagalli DA. Acute stress reduces reward responsiveness: implications for depression. Biol Psychiatry 2006; 60(10): 1147-1154 (Pubitemid 44647213)
175. Berenbaum H, Connelly J. The effect of stress on hedonic capacity. J Abnorm Psychol 1993; 102(3): 474-481
176. Pizzagalli DA, Bogdan R, Ratner KG, Jahn AL. Increased perceived stress is associated with blunted hedonic capacity: potential implications for depression research. Behav Res Ther 2007; 45(11): 2742-2753 (Pubitemid 47516710)
177. White TL, Lott DC, de Wit H. Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacology 2006; 31(5): 1064-1074
178. Cabib S, Puglisi-Allegra S. Different effects of repeated stressful experiences on mesocortical and mesolimbic dopamine metabolism. Neuroscience 1996; 73(2): 375-380 (Pubitemid 26168799)
179. Goldstein LE, Rasmusson AM, Bunney BS, Roth RH. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci 1996; 16(15): 4787-4798
180. Nestler EJ, Carlezon WA Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59(12):1151-1159
181. Berton O, McClung CA, Dileone RJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006; 311(5762): 864-868 (Pubitemid 43228853)
182. Shalev I, Lerer E, Israel S, et al. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 2009; 34(3): 382-388
183. Loas G. Vulnerability to depression: a model centered on anhedonia. J Aff Dis 1996; 41: 39-53. (Pubitemid 26364975)
184. Ventura R, Cabib S, Puglisi-Allegra S. Genetic susceptibility of mesocortical dopamine to stress determines liability to inhibition of mesoaccumbens dopamine and to behavioral 'despair' in a mouse model of depression. Neuroscience 2002; 115(4): 999-1007.